We use cookies to offer you an optimal experience on our website. By browsing our website, you accept the use of cookies.

You must be logged in to watch this video. Click here to access your account, or here to register for free!

Ablative and resective therapies of Barrett's esophagus

O Pech, MD, PHD
Epublication WebSurg.com, May 2013;13(05). URL: http://websurg.com/doi/lt03enpech001

Ask a question to the author

You must be logged in to ask a question to authors. Click here to access your account, or here to register for free!
  • 220
  • 2
  • 2013-05-13
Share it
Barrett's esophagus (BE) is the only known precursor of esophageal adenocarcinoma (EAC). Patients with BE have a 40-fold higher risk of EAC as compared with the general population. In this lecture, Dr. Oliver Pech presents the management strategies for this condition.